The FDA has signed off on emergency use of a nasal specimen self-collection kit for COVID-19 testing from Quest Diagnostics (DGX +2.3%).
The kit enables a person to swab the front part of
the nostril (instead of deep within the nasal cavity) and may be used
on children as well as adults.
Specimens are shipped overnight at room
temperature via FedEx to a Quest laboratory that will test the swab for
the presence of the SARS-CoV-2 virus.
Related ticker: LabCorp (LH +1.0%)
https://seekingalpha.com/news/3578354-fda-oks-emergency-use-of-quest-nasal-specimen-kit
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.